*Only for reading and reference by medical professionals
At 19:00 on the evening of July 10th, we are waiting for you to be lucky enough to take the stage, cook green plums and wine, and talk about breast cancer diagnosis and treatment!
"Yangtze River Drifting Bottle" is a social academic project initiated by the Yangtze River Academic Belt Breast Alliance (YBCSG), a nationally renowned breast cancer academic organization: before the meeting, we will capture the "Academic Drifting Bottle" on the latest hot topics of breast cancer, and pass Social media is a novel form of sharing academic opinions and integrating professional circles. In the conference, we will invite colleagues from the Yangtze River Academic Belt to participate, conduct a multi-dimensional inventory, advocate grand discussions and high-level remarks, and use this as a basis It serves as a media to facilitate the exchange of academic experiences and discussions on hot topics, thereby improving the level of diagnosis and treatment and promoting the standardized diagnosis and treatment of breast cancer.
From June 3 to 7, 2022, the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting arrived as scheduled, providing an online academic feast for clinical workers. Among them, another "circle-breaking" study was born in the field of breast cancer - the DESTINY-Breast04 phase III study evaluated the new antibody conjugate drug (ADC) T-DXd for the treatment of patients with metastatic breast cancer with low HER2 expression ( HER2 IHC2+/ISH-, IHC1+). The results showed that regardless of hormone receptor status, the T-DXd treatment group had a statistically significant improvement in progression-free survival and overall survival (there was no differential benefit in patients with HER2 low expression of immunohistochemistry 2+ and 1+), And regardless of whether the patient has been treated with CDK4/6 inhibitors in the past or whether he or she has visceral metastasis, all patients can benefit from T-DXd treatment. The DESTINY-Breast04 study established a new "milestone" in the treatment of HER2-negative breast cancer.
As the “academic voice” brought by the ASCO conference continues, the first online forum of "Yangtze River Drifting Bottle" "ASCO Essence - New Vision for HER2 Low Expression Treatment" (ASCO Highlight - Rising HERizon in HER2 -low BC) has arrived as scheduled and will be held online at 19:00 on July 10th.
And among the users with higher lucky scores, we will randomly select one as a guest speaker to participate in the recording of the "Yangtze River Drifting Bottle" online forum, meet with Professor Zhang Jian on the same stage, discuss heroes over wine, and share your clinical experience opinion!
The rules for scoring lucky points are as follows:
Looking for a close friend in the rolling Yangtze River - Throw the bottle:
Meet each other across thousands of rivers and mountains - Get the bottle: Click to view other people's drifting bottles to get 2~3 lucky points
Cherish each other and find a close friend - Look at the bottle : You can get 1 to 3 lucky points by expressing your attitude towards others' "view in a bottle" (3 points for full support, 2 points for partial support, 1 point for no support)
I hope you and all breast colleagues can participate in this " In the "Yangtze River Drifting Bottle" activity, we will purify our cognition and stimulate speculation, seek high opinions from the "low", break the waves at the forefront, and lead the academic trend.
The source is wandering around day and night, Yingke is late and spreads all over the world.
About the Yangtze River Academic Belt Breast Gland Alliance (YBCSG)
The Yangtze River Academic Belt Breast Gland Alliance (YBCSG) is a branch group of the Yangtze River Academic Belt Oncology Cooperative Group (YCOG). It takes the promotion of academic exchanges on breast cancer diagnosis and treatment inside and outside the Yangtze River Basin as its mission, and actively carries out breast cancer research. Multi-center clinical research; promote breast cancer professional continuing education, standardize and improve the level of breast cancer practitioners. YBCSG has opened twelve colleges, including Breast Surgery and Plastic Surgery, Radiotherapy, Targeting and Immunity, HER2 Home, Support and Rehabilitation, Diagnostics, Clinical Research, Endocrinology, Genetics and Genetics, Chemotherapy, and New The Auxiliary College and the Basic and Transformational College have received widespread attention and praise.
Currently, Professor Zhang Jian of Fudan University Affiliated Cancer Hospital serves as the chairman of YBCSG, Professor Li Hengyu of the First Affiliated Hospital of Naval Medical University serves as deputy chairman and secretary-general of YBCSG, and professors Li Wei, Professor Zheng Yabing, and Ye Songqing from all provinces and cities in the alliance Professors, Professor Han Xinghua, Professor Chen Wenyan, Professor Xiong Huihua, Professor Wang Shouman, Professor Qi Xiaowei, Professor Luo Ting, Professor Nie Jianyun, and Professor Liu Shu serve as deputy chairmen.
This article is only used to provide scientific information to medical professionals and does not represent the views of this platform
